Objectives: Coronary microembolisation in the pig heart induces angiogenesis in a model of sterile inflammation due to focal Ž . necrosis. We have recently shown in this model that insulin-like growth factor I IGF-I is involved in inflammation-linked angiogenic processes due to its enhanced transcription after 72 h of ischaemia by infiltrating monocytes in areas of microsphere-induced focal necrosis where capillary sprouting could be detected. To obtain further insights into this process we studied by means of Northern blot Ž . analysis and in situ hybridisation the gene expression of other members of the IGF family, i.e. the six IGF binding proteins IGFBPs , the insulin receptor, and the type I IGF receptor. Methods: Myocardial injury was induced by injection of 25 mm non-radioactive Ž . microspheres into the left circumflex artery LCx in pigs that were killed after 3-24, 72, or 168 h of microembolisation. Tissue was collected from a non-ischaemic control area and the LCx region of the same heart for further analysis. Results: We found decreased Ž . IGFBP-5 2.7-fold; P -0.02 mRNA concentrations after 72 h of microembolisation in ischaemic tissue versus control tissue from the Ž . same heart, preceded by a 1.9-fold elevated level of IGFBP-3 mRNA at 3-24 h P -0.05 . IGFBP-6 was increased in ischaemic tissue at all time points studied. In situ hybridisation identified myocytes as the main producers of IGFBP-3 and IGFBP-6 mRNA. The mRNA levels of IGFBP-2, IGFBP-4, the insulin receptor, and the type I IGF receptor were constitutively expressed but did not change after microembolisation. Neither in heart nor in other organs studied transcripts of IGFBP-1 could be detected. Furthermore, we demonstrated that mRNA of the other components of the IGF system was expressed in almost all porcine organs except liver. Conclusion: These results indicate a coordinate gene expression of the IGF system in microembolised porcine myocardium, compatible with a role of IGF-I, IGFBP-3, IGFBP-5, and IGFBP-6 in inflammation-linked angiogenesis andror repair processes.
Introduction
The most important strategy of the ischaemic myocardium to ensure its survival is the formation of new blood vessels. We were interested in the mechanisms leading to myocardial angiogenesis and our previous studies revealed that sprouting of new blood vessels occurred only where monocytesrmacrophages were located in close w x proximity 1 . Therefore, angiogenesis in the ischaemic heart following vascular occlusions is associated with monocytesrmacrophages synthesizing and releasing mitogens in a position where they can induce and maintain the ) Corresponding author. Max Planck Institute, Department of Experimental Cardiology, Benekestrasse 2, D-61231 Bad Nauheim, Germany.
Ž . Ž . Tel.: q49-6032 705-402 or 404; Fax: q49-6032 705-419; E-mail: rzimmer@kerckhoff.mpg.de angiogenic process. These cells have the capability to produce a multitude of growth factors among them the Ž . w x insulin-like growth factors IGFs 2 . We have shown recently in our model of microembolisation that IGF-I is involved in inflammation-linked angiogenic processes due to its enhanced transcription by infiltrating monocytes in areas of microsphere-induced focal necrosis where capilw x lary sprouting could be detected 3 . In contrast, the gene expression of the related polypeptide IGF-II remained unaltered.
Our interest to elucidate the molecular mechanisms leading to angiogenesis prompted us to study the gene expression of the whole IGF system whose components, besides IGF-I, may also be influenced by coronary mi-croembolisation. The IGFs can bind to six different IGF Ž . w x binding proteins IGFBPs 4,5 . Their major function is believed to be the modulation of the action of IGF by regulating its bioavailability to target tissues. The IGFBPs act as bipotential regulators, i.e., they can either inhibit or potentiate IGF-promoted growth. Since the IGFBPs posses a higher affinity for the ligand than the IGF receptors they can prevent the IGFs from stimulating receptor function w x 4,5 . However, the exact physiological roles of the IGFw x BPs, especially in the cardiovascular system 6 , are still under investigation. The mitogenic and insulin-like metabolic effects are mediated by the type I IGF receptor w x and the insulin receptor 7 . The contribution of the six IGFBPs and the IGF receptors to angiogenic processes after microembolisation was evaluated in the same pigs w x already studied for IGF-I expression 3 by examining the temporal and regional differences in the expression of their mRNAs using Northern blot analysis and in situ hybridisation. In our porcine model of microembolisation ischaemia was induced by the injection of microspheres that leads to sterile inflammation in areas of focal necrosis followed by angiogenesis. Since the onset of ischemia is precisely known, this model is particularly suited for studies of the time course of growth factor expression. Furthermore, we examined the gene expression of the IGFBPs and the IGF receptors in various porcine organs.
Materials and methods

Preparation of animals
The experimental protocol described in this study was approved by the Bioethical Committee of the District of Darmstadt, Germany. Furthermore, all animals in this study were handled in accordance with the American Physiological Society guidelines for animal welfare and the investigation conformed with the Guide for Care . lands into the LCx distal to the first marginal branch. The catheter was removed, the carotid artery ligated, and the neck incision repaired. The pigs were killed at different time intervals after microembolisation, i.e., at 3-24 h Ž . Ž . Ž . ns5 , 72 h n s 5 , and 168 h n s 5 , the heart was excised, and tissue samples were collected from the control non-ischaemic intraventricular septum and from the ischaemic LCx-perfused embolised region, i.e., the left ventricular free wall between the anterior and posterior papillary muscle. One sham-operated pig underwent catheterisation as described, except that only saline was injected, and was killed after 24 h. For gene expression studies, samples from the same hearts in which we have measured the w x changes in IGF-I gene expression 3 were used. Moreover, non-sham controls were studied as well. These animals were anaesthetised with pentobarbital sodium as described above and afterwards killed by an overdose of pentobarbital sodium and by an intravenous injection of 20% potassium chloride. Tissue samples were snap-frozen in liquid nitrogen and stored at y808C until use.
Molecular probes
The murine 18S ribosomal RNA cDNA probe was a w x generous gift of I. Oberbaumer 9 . The probe for human w x IGFBP-1 was kindly provided by A.G.P. Schuller 10 , that w x for ovine IGFBP-2 by V.K.M. Han 11 , the one for w x porcine IGFBP-3 by S. Shimasaki 12 , and those for Ž human IGFBP-4 to -6 by M.C. Kiefer Chiron Coopera-
. w x tion, Emeryville, USA 13,14 . The probes for the human insulin receptor and human type I IGF receptor were Ž . purchased from ATCC Rockville, USA .
For Northern blot analysis, cDNA probes were labelled by random priming to a specific activity of about 10 8 Ž . cpmrmg using the prime-a-gene labelling kit Promega w 32 x Ž . and 40 mCi of a-P dCTP 3000 Cirmmol, Amersham . The IGFBP-1 probe was a EcoRI insert of 1.2 kb, the IGFBP-2 probe a 690 bp AccI-SphI fragment, the IGFBP-3 probe a 600 bp EcoRI-SmaI insert, the IGFBP-4 probe a 800 bp HindIII-EcoRI fragment, the IGFBP-5 probe a 660 bp EcoRI-PstI insert, and the IGFBP-6 probe a 980 bp EcoRI fragment. For the insulin receptor a 900 bp EcoRIBamHI fragment and for the type I IGF-receptor a 700 bp EcoRI or a 520 bp EcoRI-PÕuII insert were used. The 18S cDNA probe was a 770 bp EcoRI-BamHI fragment.
Northern blot analysis and quantification
Total RNA from frozen heart tissue was isolated acw x cording to the method of Chomczynski and Sacchi 15 . 15 mg of total RNA from control and experimental tissue of the same heart were size-fractionated as pairs on a 1% agarose gel containing 0.66 M formaldehyde. Blotting and w x hybridisation were performed as already described 3 . After washing to a final stringency of 0.2 = SSCr0.1% SDS at 608C and quantification of the signals, filters were Ž . microembolisation. Total RNA from the control region C as well as the experimental microembolised area E of the same heart were loaded as pairs. In the time window 3-24 h is blotted RNA of one myocardium after 3, 6, and 12 h of ischaemia, and of two hearts after 24 h of microembolisation, Ž . respectively. Pigs which underwent thoracotomy are marked with q . To control for RNA loading the blot was rehybridised with an 18S rRNA probe Ž . lower panel . The approximate size of the mRNA bands is expressed in kilobases.
Ž . exposed at y808C to X-OMAT AR films Kodak using intensifying screens for up to 8 days. Filters were sequentially hybridised with different probes and finally rehyw x bridised with an 18S cDNA probe for control purposes 9 . Additionally, each gel was done at least in duplicate to control for variability within and between gels.
The signals were quantified with a PhosphorImager Ž . Molecular Dynamics, Krefeld, Germany using ImageQuant software. For normalisation, the data of each hybridisation signal were divided by the values for the matching 18S signal. The data obtained for the cardiac control tissue of the sham-operated pig were set at 100%. All values were presented as mean " s.e.m. The difference in the expression between the microembolised region and the control area was assessed by a paired two tailed t test. Statistical significance was accepted at P -0.05.
In situ hybridisation analysis
For in situ hybridisations of IGFBP-3 and IGFBP-6, in vitro transcription techniques were used. First 1 mg of cDNA, linearised with the appropriate restriction enzyme, was transcribed using T3 RNA-polymerase or T7 RNAw 35 x Ž polymerase and 100 mCi of a-S UTP 1000 Cirmmol, . Amersham to generate antisense and sense RNAs. After digestion with RNase-free DNase and a subsequent precipitation, the labelled RNAs were redissolved in 100 ml Ž . 0.01 M dithiothreitol DTT . Since the transcripts were larger than 500 bp, the IGFBP-3 and IGFBP-6 mRNAs were subjected to hydrolysis by addition of 100 ml hydrol-Ž ysis buffer 0.08 M NaHCO , 0.02 M Na CO , 0.02 M 3 2 3 . mercaptoethanol, pH 9 at 608C for 15 or 21 min, respectively. The reaction was stopped with 200 ml hydrolysis-Ž stop-buffer 0.2 M sodium acetate pH 6, 1% acetic acid, . 0.01 M DTT . The precipitated labelled transcripts were redissolved in 0.1 M DTT and stored at y808C. The treatment of sections with the respective labelled RNA probes was performed as already described by Kluge et al. w x 3 .
Results
Gene expression of IGFBPs in normal and microembolised myocardium
IGFBP-5 expressed in porcine myocardium a transcript Ž . of 6.0 kb Fig. 1 . After 3-24 h of microembolisation we observed a weak decrease in the IGFBP-5 mRNA concentration in the experimental region compared to the control Ž . area of the heart Fig. 1 and Fig. 2 . 72 h of ischaemia led to a significant 2.7-fold decline of the IGFBP-5 transcripts Ž . in the experimental region P -0.02 . 168 h after the onset of microembolisation the IGFBP-5 mRNA level in the experimental region was again equivalent to that in the control area of the myocardium.
In normal and ischaemic porcine heart a transcript of Ž . 2.6 kb was expressed for IGFBP-3 Fig. 1 . Only after 3-24 h of microembolisation we observed a significantly Ž 1.9-fold elevated IGFBP-3 mRNA concentration P -. 0.05 in the experimental region in comparison with the Ž . corresponding control area of the heart Figs. 1 and 3 . There was also a noticeable tendency to an increase in IGFBP-3 transcripts in the control region after 3-24 h of ischaemia compared to the IGFBP-3 mRNA concentration in the control area of the sham-operated pig. However, interpretation may be difficult due to the small number of sham-operated pigs although in our opinion the values of the sham-operated animal are representative because they are comparable with those of non-operated control animals Ž . unpublished observation .
In situ hybridisation studies showed that myocytes were the main producers of IGFBP-3 mRNA in normal and Ž . microembolised myocardium Fig. 4A . We observed intense labelling with the IGFBP-3 cRNA probe in single cardiac myocytes. Furthermore, we could determine some Ž isolated labelled fibroblasts in the interstitial space 
Ž
. porcine myocardium Fig. 1 . At all examined time points after the onset of ischaemia the gene expression of IGFBP-6 was elevated in the experimental heart region in compari-Ž . son with the corresponding control area Figs. 1 and 5 . Similar to the observation with IGFBP-3, we could again notice after 3-72 h of microembolisation a tendency to an increase in IGFBP-6 transcripts in the control area compared to the control region of the sham-operated pig. After 168 h of microembolisation there was still a significant 2.1-fold enhancement in the IGFBP-6 mRNA concentration in the microembolised area compared to the corre-Ž . sponding control region P -0.05 . In situ hybridisation studies revealed an intense transcription of IGFBP-6 by Ž . single myocytes Fig. 6A . Occasionally, we detected la-Ž . belled fibroblasts in the interstitial space Fig. 6A . In the microembolised myocardium a part of the rare signals could be attributed to macrophages because a clear identification of the interstitial cell types was not always possible. Although there were differences in the IGFBP-6 mRNA concentration in the experimental and control region we could not identify the cell type which was respon- No transcripts of IGFBP-1 could be detected by means of Northern blot hybridisation in normal as well as ischaemic porcine myocardium independent of the duration of microembolisation. IGFBP-2 expressed a mRNA species of 2.0 kb in porcine heart and its level remained unaltered Fig. 6 . In situ hybridisation of IGFBP-6 mRNA in microembolised porcine heart. Single myocytes could be identified as the main producers of IGFBP-6 Ž . Ž . mRNA in porcine heart. Ocassionally, we detected labelled fibroblasts arrow in the interstitium A . Panel B demonstrates the control hybridisation of Ž . cardiac tissue with IGFBP-6 sense RNA probe magnification: 500= .
Downloaded from https://academic.oup.com/cardiovascres/article-abstract/33/2/324/378978 by guest on 13 January 2018 ( )during our microembolisation protocol. Furthermore, we observed no influence of microembolisation on the constitutive cardiac expression of the 2.3 kb mRNA of IGFBP-4.
Gene expression of IGF receptors in normal and microembolised myocardium
The insulin receptor to which the IGFs bind with low w x affinity 7 expressed a transcript of 11.0 kb in porcine Ž . myocardium Fig. 7A . No alteration in the gene expression of the insulin receptor was found during microembolisation, except for a tendency to a decrease at 72 h.
Three transcripts of 11.0, 7.0 and 0.7 kb for the type I Ž IGF receptor were detected in porcine myocardium Fig. . 7B . The expression of an 0.7 kb type I IGF receptor mRNA was recently also described for pig granulosa cells w x 16 , but it is obvious that an mRNA of this size can not Ž encode for a protein as large as the type I IGF receptor a
. w x subunit: 80 kDA; b subunit: 70 kDa 17 . Therefore, it was highly probable that the 0.7 kb mRNA was a degradation product. There was a declining trend toward lower expression of the 11.0 and 7.0 kb transcripts at 72 h. However, for the 0.7 kb mRNA we could observe at this time point neither an increase as it would be expected in the case of degradation nor the same decrease as determined for the two larger mRNA bands. The expression of the 0.7 kb transcript remained constant during microembolisation. Because the 0.7 kb mRNA band could not directly be assigned to the type I IGF receptor due to size and expression behaviour, it was not taken into account during our studies. In the course of microembolisation there were no significant changes in the gene expression of the type I IGF receptor and we observed the same tendency to a decrease after 72 h of ischaemia as already described for the insulin receptor.
Expression of the IGF system in different porcine organs
The gene expression of the components of the IGF system in various porcine organs is shown in table 1. In all swine organs studied no transcripts for IGFBP-1 were found by means of Northern blot hybridisation. IGFBP-2 and IGFBP-3 mRNA were expressed in all tissues examined with the highest level of expression in kidney and liver. The IGFBP-4 mRNA concentration was nearly equal in all the different tissues whereas IGFBP-5 showed its highest expression in kidney followed by heart and was undetectable in liver. IGFBP-6 mRNA also could not be detected in liver and its mRNA level was highest in skeletal muscle and brain. mRNA of the insulin receptor was neither detected in liver nor in spleen but it was well expressed in kidney and in left ventricle. Additionally, the type I IGF receptor showed no mRNA expression in liver but a strong gene expression in kidney and heart.
Discussion
Coordinate expression of the IGF system in microembolised myocardium
We have previously shown that in porcine myocardium coronary microembolisation causes the induction of areas of focal necrosis with subsequent formation of new capilw x laries 1 . At 72 h of ischaemia mitosis of endothelial cells w x could be observed 1 together with an increased gene expression of IGF-I by monocytesrmacrophages in the necrotic areas, leading to our conclusion that IGF-I is involved in the inflammation-linked angiogenic processes w x after microembolisation 3 . These results prompted us to study in the same microembolised hearts the changes in the expression of genes that are known to influence the activity of IGF-I. Since we show that the gene expression Ž of the insulin and type I IGF receptor remained constant a similar observation was made during the wound healing of rats where the type I IGF receptor mRNA level was
. w x unaltered 18 the IGFBPs seem to be important control points for determining tissue-specific responses to IGF-I by regulating the localisation to specific tissues and by w x modulating the receptor interactions 5 . The most important findings of this study are the alterations in gene expression of IGFBP-5, IGFBP-3, and IGFBP-6.
After 72 h of microembolisation we observed a decrease in IGFBP-5 mRNA expression which coincides with our previously described increase in IGF-I gene expression. IGFBPs in the extracellular space are known to inhibit the action of IGF-I due to their higher affinity for w x this protein than the IGF receptors 4,5 . Because the alteration in gene expression of the two components of the IGF system occurs in opposite directions we conclude that cardiac IGFBP-5 inhibits the action of IGF-I and that its expression will therefore be downregulated in the case IGF-I is needed during angiogenic andror repair processes after microembolisation. Our group has meanwhile shown Ž . Vogt et al., submitted that IGFBP-5 counteracts the trophic effects of IGF-II. It is therefore highly likely that it may also inhibit IGF-I.
The increase in gene expression of IGFBP-3 after 3-24 h of microembolisation preceded that of IGF-I. Because IGFBP-3 has a higher affinity for the ligand than the receptor, IGFBP-3 is in principle able to inhibit the mitow x genic action of IGF-I 4,5 . But when IGFBP-3 could adhere to the cell surface before it binds to IGF-I, as it would be the case in an expression preceding IGF-I, a decrease in the affinity of the binding protein towards the ligand occurs which leads to an enhanced mitogenic affinw x ity of IGF-I 19 . Therefore, IGFBP-3 may facilitate proliferative effects on endothelial cells. Furthermore, recent evidence suggests that under certain conditions IGFBP-3 may be acting independently even in the absence of IGF w x via specific membrane association proteins 20 . However, it was shown that IGFBP-3 and IGF-I may play a role in ( )w x mediating angiogenesis in the retina 21 . Furthermore, IGFBP-3 could contribute to the modulation in receptor density because this binding protein is capable to inhibit w x the internalisation of the type I IGF receptor 22 . IGFBP-3, complexed with IGF-I, enhanced the collagen synthesis during wound healing in rat and promoted wound healing w x in pig more efficiently than IGF-I alone 23 . Because of its early induction IGFBP-3 seems not to contribute to the increase in collagen synthesis which was observed 168 h w x after the onset of microembolisation 1 .
We show that IGFBP-3 was mainly transcribed by cardiac myocytes and another hypothesis would be that IGFBP-3 exerts an autocrine function on myocytes. Through binding to the cell surface of ischaemia stressed myocytes IGFBP-3 could selectively promote insulin-like metabolic effects in a surrounding with a constant IGF-I concentration. This idea of a trophic factor would explain the fact of the slight increase in IGFBP-3 mRNA concentration in the control region after 3 to 24 h of microembolisation where the IGF-I concentration remained constant w x 3 . Protective effects in non-ischaemic control heart regions, i.e., an increased ischaemic tolerance, have been w x observed after brief coronary occlusions 24 .
Finally, we demonstrated an enhanced gene expression of IGFBP-6 during the whole time course of microembolisation. Studies of IGFBP-6 in vivo as well as in vitro are quite limited making it difficult to hypothesise about the possible function of IGFBP-6 in microembolised heart. A regulation of the activity of IGF-I through a binding of IGFBP-6 to the cell surface, as it was reported for IGFBP-3, has not been demonstrated. It may be speculated that due to the fact that the induction of IGFBP-6 preceded that of IGF-I the possible function may be a potentiation of the cardiac angiogenic activity of IGF-I. Otherwise, due to its main transcription by myocytes and its slightly increased expression in the non-ischaemic control region IGFBP-6 may act as a trophic factor for myocytes in the same way as already discussed for IGFBP-3.
A further regulation may occur at the posttranslational level by means of phoshorylation or proteolysis of the w x IGFBPs 5 . Therefore, the fact that IGFBP-2 and IGFBP-4 were constantly expressed does not indicate that they are not involved in the angiogenic processes following microembolisation. Moreover, posttranslational modifications of the IGFBPs which showed changes in their mRNA level could also enhance or reduce their biological effect. Since the IGFBPs are bipotential regulators and because our in vivo studies are of descriptive nature further experiments have to be done to elucidate the complex function and mechanism of the IGF system.
The IGF system is ubiquitously expressed in porcine organs
Apart from IGFBP-1 we observed that mRNA of all the components of the IGF system was expressed in almost all porcine tissues, except liver. Therefore, this system must have a general physiological role and the relative ratio between the components seems to determine their activity. There was a noticeable lack of IGF receptor gene expression in porcine liver which could be due to the fact that w x this organ is the major source of endocrine IGF 7 . Additionally, the absence of type I IGF receptor transcripts w x was reported for human and rat liver 25 . The ubiquitous expression of the IGF system indicates an auto-andror paracrine function in the different tissues.
Conclusions
The IGF system is complex and the myriad possible interactions of its components likely accounts for functional diversity, the extent of which is beginning to be understood. We were especially interested in the function of the IGF system in the angiogenesis following microembolisation in porcine myocardium and we could observe a coordinate alteration in gene expression of IGF-I, IGFBP-3, IGFBP-5, and IGFBP-6. Therefore, we conclude that IGFBP-3, IGFBP-5, and IGFBP-6 in association with IGF-I may play an important role during inflammation-linked angiogenesis andror repair processes after microembolisation. Because of the constitutive transcription the relative ratio between the components primarily seems to determine the potency of IGF-I before other mechanisms come into play. A coordinate regulation among the IGFBPs may be important in achieving balanced growth. Particularly, since IGF receptors are ubiquitously present on cell types derived from all three embryonic lineages, the IGFBPs may perform an important function in determining the cellular responsiveness among cell types with similar rew x ceptor distribution 5 .
